463 related articles for article (PubMed ID: 28900730)
1. Review of local injection of anti-TNF for perianal fistulising Crohn's disease.
Adegbola SO; Sahnan K; Tozer PJ; Phillips RK; Faiz OD; Warusavitarne J; Hart A
Int J Colorectal Dis; 2017 Nov; 32(11):1539-1544. PubMed ID: 28900730
[TBL] [Abstract][Full Text] [Related]
2. Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment.
de Groof EJ; Sahami S; Lucas C; Ponsioen CY; Bemelman WA; Buskens CJ
Colorectal Dis; 2016 Jul; 18(7):667-75. PubMed ID: 26921847
[TBL] [Abstract][Full Text] [Related]
3. Defining and predicting deep remission in patients with perianal fistulizing Crohn's disease on anti-tumor necrosis factor therapy.
Papamichael K; Cheifetz AS
World J Gastroenterol; 2017 Sep; 23(34):6197-6200. PubMed ID: 28974885
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].
Bor R; Farkas K; Bálint A; Szűcs M; Abrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
Orv Hetil; 2013 Dec; 154(49):1943-8. PubMed ID: 24292112
[TBL] [Abstract][Full Text] [Related]
5. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.
Tonelli F; Giudici F; Asteria CR
Dis Colon Rectum; 2012 Aug; 55(8):870-5. PubMed ID: 22810472
[TBL] [Abstract][Full Text] [Related]
7. The long-term outcome of anti-TNF alpha therapy in perianal Crohn's disease.
Rayen J; Currie T; Gearry RB; Frizelle F; Eglinton T
Tech Coloproctol; 2017 Feb; 21(2):119-124. PubMed ID: 28066859
[TBL] [Abstract][Full Text] [Related]
8. Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.
Bouchard D; Abramowitz L; Bouguen G; Brochard C; Dabadie A; de Parades V; Eléouet-Kaplan M; Fathallah N; Faucheron JL; Maggiori L; Panis Y; Pigot F; Rouméguère P; Sénéjoux A; Siproudhis L; Staumont G; Suduca JM; Vinson-Bonnet B; Zeitoun JD
Tech Coloproctol; 2017 Sep; 21(9):683-691. PubMed ID: 28929282
[TBL] [Abstract][Full Text] [Related]
9. Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn's disease.
Yassin NA; Askari A; Warusavitarne J; Faiz OD; Athanasiou T; Phillips RK; Hart AL
Aliment Pharmacol Ther; 2014 Oct; 40(7):741-9. PubMed ID: 25115149
[TBL] [Abstract][Full Text] [Related]
10. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL
J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625
[TBL] [Abstract][Full Text] [Related]
11. Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal Fistulas.
De Gregorio M; Lee T; Krishnaprasad K; Amos G; An YK; Bastian-Jordan M; Begun J; Borok N; Brown DJM; Cheung W; Connor SJ; Gerstenmaier J; Gilbert LE; Gilmore R; Gu B; Kutaiba N; Lee A; Mahy G; Srinivasan A; Thin L; Thompson AJ; Welman CJ; Yong EXZ; De Cruz P; van Langenberg D; Sparrow MP; Ding NS
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1306-1314. PubMed ID: 34389484
[TBL] [Abstract][Full Text] [Related]
12. The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn's disease.
Haennig A; Staumont G; Lepage B; Faure P; Alric L; Buscail L; Bournet B; Moreau J
Colorectal Dis; 2015 Apr; 17(4):311-9. PubMed ID: 25425534
[TBL] [Abstract][Full Text] [Related]
13. Managing perianal Crohn's fistula in the anti-TNFα era.
Tozer P; Borowski DW; Gupta A; Yassin N; Phillips R; Hart A
Tech Coloproctol; 2015 Nov; 19(11):673-8. PubMed ID: 26264168
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease.
Thomassin L; Armengol-Debeir L; Charpentier C; Bridoux V; Koning E; Savoye G; Savoye-Collet C
World J Gastroenterol; 2017 Jun; 23(23):4285-4292. PubMed ID: 28694669
[TBL] [Abstract][Full Text] [Related]
15. Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease.
Gu B; Venkatesh K; Williams AJ; Ng W; Corte C; Gholamrezaei A; Ghaly S; Xuan W; Paramsothy S; Connor S
World J Gastroenterol; 2022 Jun; 28(23):2597-2608. PubMed ID: 35949350
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Perianal Fistulising Crohn's Disease Following Anti-TNFα Treatment Discontinuation.
Legué C; Brochard C; Bessi G; Wallenhorst T; Dewitte M; Siproudhis L; Bouguen G
Inflamm Bowel Dis; 2018 May; 24(6):1107-1113. PubMed ID: 29733370
[TBL] [Abstract][Full Text] [Related]
17. Lack of anti-TNF drugs levels in fistula tissue - a reason for nonresponse in Crohn's perianal fistulating disease?
Adegbola SO; Sarafian M; Sahnan K; Pechlivanis A; Phillips RKS; Warusavitarne J; Faiz O; Haddow J; Knowles C; Tozer P; Holmes E; Hart A
Eur J Gastroenterol Hepatol; 2022 Jan; 34(1):18-26. PubMed ID: 33522723
[TBL] [Abstract][Full Text] [Related]
18. Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease.
Plevris N; Jenkinson PW; Arnott ID; Jones GR; Lees CW
Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):32-37. PubMed ID: 31567638
[TBL] [Abstract][Full Text] [Related]
19. Strategies to Optimize Anti-tumor Necrosis Factor Therapy for Perianal Fistulizing Crohn's Disease: A Systematic Review.
Tandon P; Rhee GG; Schwartz D; McCurdy JD
Dig Dis Sci; 2019 Nov; 64(11):3066-3077. PubMed ID: 31030304
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.
Bor R; Farkas K; Bálint A; Szucs M; Ábrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
Scand J Gastroenterol; 2015 Feb; 50(2):182-7. PubMed ID: 25384713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]